20 May 2026
New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices
Anchorperson:
T. Rudolph
Spokesperson:
A. Baumbach
Summary
This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic regurgitation management.
Learning Objectives
- To recognise the challenges of TAVI for pure aortic regurgitation
- To understand how best to treat pure aortic regurgitation with conventional transcatheter heart valves
- To learn more about dedicated devices for TAVI in aortic regurgitation